New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles

Current B-cell disorder treatments take advantage of dose-intensive chemotherapy regimens and immunotherapy via use of monoclonal antibodies. Unfortunately, they may lead to insufficient tumor distribution of therapeutic agents, and often cause adverse effects on patients. In this contribution, we p...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mezzaroba, Nelly, Zorzet, Sonia, Secco, Erika, Biffi, Stefania, Tripodo, Claudio, Calvaruso, Marco, Mendoza-Maldonado, Ramiro, Capolla, Sara, Granzotto, Marilena, Spretz, Ruben, Larsen, Gustavo, Noriega, Sandra, Lucafò, Marianna, Mansilla, Eduardo, Garrovo, Chiara, Marín, Gustavo H., Baj, Gabriele, Gattei, Valter, Pozzato, Gabriele, Núñez, Luis, Macor, Paolo
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2013
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787049/
https://ncbi.nlm.nih.gov/pubmed/24098639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0074216
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים